208 related articles for article (PubMed ID: 30275766)
1. The Relationship between Follicle-stimulating Hormone and Bone Health: Alternative Explanation for Bone Loss beyond Oestrogen?
Chin KY
Int J Med Sci; 2018; 15(12):1373-1383. PubMed ID: 30275766
[TBL] [Abstract][Full Text] [Related]
2. [Bone metabolism by sex hormones and gonadotropins].
Imai Y
Clin Calcium; 2014 Jun; 24(6):815-9. PubMed ID: 24870831
[TBL] [Abstract][Full Text] [Related]
3. Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation.
Wang J; Zhang W; Yu C; Zhang X; Zhang H; Guan Q; Zhao J; Xu J
PLoS One; 2015; 10(8):e0134986. PubMed ID: 26241313
[TBL] [Abstract][Full Text] [Related]
4. FSH directly regulates bone mass.
Sun L; Peng Y; Sharrow AC; Iqbal J; Zhang Z; Papachristou DJ; Zaidi S; Zhu LL; Yaroslavskiy BB; Zhou H; Zallone A; Sairam MR; Kumar TR; Bo W; Braun J; Cardoso-Landa L; Schaffler MB; Moonga BS; Blair HC; Zaidi M
Cell; 2006 Apr; 125(2):247-60. PubMed ID: 16630814
[TBL] [Abstract][Full Text] [Related]
5. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation.
Iqbal J; Sun L; Kumar TR; Blair HC; Zaidi M
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14925-30. PubMed ID: 17003115
[TBL] [Abstract][Full Text] [Related]
6. Follicle-stimulating hormone does not impact male bone mass in vivo or human male osteoclasts in vitro.
Ritter V; Thuering B; Saint Mezard P; Luong-Nguyen NH; Seltenmeyer Y; Junker U; Fournier B; Susa M; Morvan F
Calcif Tissue Int; 2008 May; 82(5):383-91. PubMed ID: 18465073
[TBL] [Abstract][Full Text] [Related]
7. FSH versus estrogen: who's guilty of breaking bones?
Baron R
Cell Metab; 2006 May; 3(5):302-5. PubMed ID: 16679287
[TBL] [Abstract][Full Text] [Related]
8. New insights: elevated follicle-stimulating hormone and bone loss during the menopausal transition.
Zaidi M; Blair HC; Iqbal J; Davies TF; Zhu LL; Zallone A; Sun L
Curr Rheumatol Rep; 2009 Jul; 11(3):191-5. PubMed ID: 19604463
[TBL] [Abstract][Full Text] [Related]
9. Blocking FSH action attenuates osteoclastogenesis.
Zhu LL; Tourkova I; Yuen T; Robinson LJ; Bian Z; Zaidi M; Blair HC
Biochem Biophys Res Commun; 2012 May; 422(1):54-8. PubMed ID: 22561017
[TBL] [Abstract][Full Text] [Related]
10. Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis.
Zhu LL; Blair H; Cao J; Yuen T; Latif R; Guo L; Tourkova IL; Li J; Davies TF; Sun L; Bian Z; Rosen C; Zallone A; New MI; Zaidi M
Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14574-9. PubMed ID: 22908268
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological estrogen administration causes a FSH-independent osteo-anabolic effect requiring ER alpha in osteoblasts.
Seitz S; Keller J; Schilling AF; Jeschke A; Marshall RP; Stride BD; Wintermantel T; Beil FT; Amling M; Schütz G; Tuckermann J; Schinke T
PLoS One; 2012; 7(11):e50301. PubMed ID: 23209701
[TBL] [Abstract][Full Text] [Related]
12. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
13. [Bone and calcium metabolism in menopause transition].
Terauchi M
Clin Calcium; 2011 Sep; 21(9):1353-9. PubMed ID: 21881198
[TBL] [Abstract][Full Text] [Related]
14. An activated human follicle-stimulating hormone (FSH) receptor stimulates FSH-like activity in gonadotropin-deficient transgenic mice.
Haywood M; Tymchenko N; Spaliviero J; Koch A; Jimenez M; Gromoll J; Simoni M; Nordhoff V; Handelsman DJ; Allan CM
Mol Endocrinol; 2002 Nov; 16(11):2582-91. PubMed ID: 12403847
[TBL] [Abstract][Full Text] [Related]
15. FSH aggravates bone loss in ovariectomised rats with experimental periapical periodontitis.
Qian H; Guan X; Bian Z
Mol Med Rep; 2016 Oct; 14(4):2997-3006. PubMed ID: 27510616
[TBL] [Abstract][Full Text] [Related]
16. Extragonadal Effects of Follicle-Stimulating Hormone on Osteoporosis and Cardiovascular Disease in Women during Menopausal Transition.
Zhu D; Li X; Macrae VE; Simoncini T; Fu X
Trends Endocrinol Metab; 2018 Aug; 29(8):571-580. PubMed ID: 29983231
[TBL] [Abstract][Full Text] [Related]
17. Proresorptive actions of FSH and bone loss.
Zaidi M; Blair HC; Iqbal J; Zhu LL; Kumar TR; Zallone A; Sun L
Ann N Y Acad Sci; 2007 Nov; 1116():376-82. PubMed ID: 18083939
[TBL] [Abstract][Full Text] [Related]
18. Further evidence for direct pro-resorptive actions of FSH.
Sun L; Zhang Z; Zhu LL; Peng Y; Liu X; Li J; Agrawal M; Robinson LJ; Iqbal J; Blair HC; Zaidi M
Biochem Biophys Res Commun; 2010 Mar; 394(1):6-11. PubMed ID: 20171951
[TBL] [Abstract][Full Text] [Related]
19. Immunization with FSHβ fusion protein antigen prevents bone loss in a rat ovariectomy-induced osteoporosis model.
Geng W; Yan X; Du H; Cui J; Li L; Chen F
Biochem Biophys Res Commun; 2013 May; 434(2):280-6. PubMed ID: 23537645
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal osteoporosis: the role of immune system cells.
Faienza MF; Ventura A; Marzano F; Cavallo L
Clin Dev Immunol; 2013; 2013():575936. PubMed ID: 23762093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
